Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze DAWN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate DAWN investment potential.

What is DAWN stock price today?

Get real-time DAWN stock price, historical data, and price charts on Financhill. Track DAWN performance with our advanced analysis tools.

Is DAWN a good investment?

Evaluate DAWN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy DAWN stock?

To buy DAWN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of DAWN?

View detailed market capitalization data and company valuation metrics for DAWN on our comprehensive analysis page.

What is the P/E ratio of DAWN?

Use our fundamental analysis tools to view DAWN P/E ratio and compare valuation metrics with industry peers.

What are DAWN earnings?

View DAWN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Day One Biopharmaceuticals, Inc. Stock Predictions

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Buy

DAWN
Day One Biopharmaceuticals, Inc.

Last Price:

$10.53

Seasonality Move:

-29.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Exxon and Chevron Have an Unlikely New Competitor

Day One Biopharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Day One Biopharmaceuticals, Inc. has on average historically fallen by 9.7% based on the past 4 years of stock performance.
Day One Biopharmaceuticals, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Is Day One Biopharmaceuticals, Inc. Stock Undervalued?

The current Day One Biopharmaceuticals, Inc. [DAWN] share price is $10.73. The Score for DAWN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
DAWN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Day One Biopharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Day One Biopharmaceuticals, Inc. has on average historically fallen by 9.7% based on the past 4 years of stock performance.

Day One Biopharmaceuticals, Inc. Stock Rating

Buy

Day One Biopharmaceuticals, Inc. (DAWN) is a Buy

Is Day One Biopharmaceuticals, Inc. overpriced?

Day One Biopharmaceuticals, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Day One Biopharmaceuticals, Inc. Stock Price History

Is DAWN stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAWN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

dayonebio.com

52-Week Data

52-Week High:

13.53

52-Week Low:

5.64

Prediction Charts

Market Cap:

1.1B

Price in USD:

10.73

Volume:

2.1M

Beta:

-1.29

Technical Analysis

SMA50:

9.01

SMA100:

8.13

SMA200:

7.48

52-Wk Change:

-3.85%

Stock Predictions

Is Day One Biopharmaceuticals, Inc. stock public?

Yes, Day One Biopharmaceuticals, Inc. is a publicly traded company.
What is the Day One Biopharmaceuticals, Inc. stock quote today?

The Day One Biopharmaceuticals, Inc. stock price is 10.73 USD today.
How to buy Day One Biopharmaceuticals, Inc. stock online?

You can buy Day One Biopharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-23	9.49	9.63	9.73	9.35
Dec-24	9.61	9.60	9.82	9.51
Dec-26	9.58	9.45	9.65	9.44
Dec-29	9.36	9.37	9.45	9.26
Dec-30	9.35	9.18	9.59	9.10
Dec-31	9.20	9.32	9.37	9.12
Jan-5	8.85	8.55	8.87	8.35
Jan-6	8.55	8.64	8.74	8.43
Jan-7	8.70	9.61	9.65	8.68
Jan-8	9.51	9.25	9.71	9.15
Jan-9	9.34	8.94	9.58	8.92
Jan-12	10.83	11.33	11.55	10.45
Jan-13	11.65	10.59	11.65	10.16
Jan-14	10.63	10.73	10.75	10.26

Day One Biopharmaceuticals, Inc. Earnings

Day One Biopharmaceuticals, Inc. Earnings Report: Per Share Day One Biopharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Day One Biopharmaceuticals, Inc. Forecast Revenue Growth

Day One Biopharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Day One Biopharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.74 per share.

* Day One Biopharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.